Medtronic To Acquire Titan Spine for its Portfolio of Implants and nanoLock Surface Technology
Shots:
- Medtronic acquires Titan Spine- in all-stock transaction. The acquisition is expected to close on July 26- 2019 including regulatory clearance
- The focus of the acquisition is to bolster Medtronic’s Spine portfolio with the addition of Titan’s spine implant surface technology and surface-enhanced interbody implants- providing complete procedural solutions for surgeons and improving patient’s outcomes
- Titan’s nanoLock is a surface technology enhancing micro and nano-scaled architecture thus improving the osteogenic response and has received FDA’s nano-clearance & Centers for Medicare & Medicaid Services (CMS) new technology designation
Ref: GlobeNewsWire | Image: Ti Group
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com